Patents by Inventor Alain Goossens

Alain Goossens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11208667
    Abstract: This disclosure relates to the field of secondary metabolite production in plants. More specifically, the disclosure relates to chimeric genes encoding a bHLH protein of subfamily Iva comprising a bHLH domain and their use in the regulation of biosynthesis and/or production of secondary metabolites in plants and plant-derived cell cultures.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: December 28, 2021
    Assignees: VIB VZW, Universiteit Gent, Universiteit Leiden
    Inventors: Alain Goossens, Jan Mertens, Alex Van Moerkercke, Jacob Pollier, Johan Memelink
  • Publication number: 20200385762
    Abstract: The present application relates to the field of terpenoid production technologies, particularly to production technologies using recombinant eukaryotic cells, and the improvement thereof. In particular, the present invention relates to recombinant eukaryotic cells capable of producing increased yields of terpenoids. Accordingly, the invention provides eukaryotic cells wherein intracellular membrane proliferation is affected and as such stimulated. The invention as well provides methods for the production of said cells.
    Type: Application
    Filed: November 27, 2017
    Publication date: December 10, 2020
    Inventors: Alain Goossens, Philipp Arendt, Nico Callewaert
  • Patent number: 10370672
    Abstract: This disclosure relates to the field of secondary metabolite production in plants. More specifically, the disclosure relates to chimeric genes and their use in the regulation of biosynthesis and/or production of secondary metabolites in plants and plant-derived cell cultures.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: August 6, 2019
    Assignees: VIB XVZW, UNIVERSITEIT GENT, UNIVERSITEIT LEIDEN
    Inventors: Alain Goossens, Jan Mertens, Alex Van Moerkercke, Jacob Pollier, Johan Memelink
  • Publication number: 20190071686
    Abstract: This disclosure relates to the field of secondary metabolite production in plants. More specifically, the disclosure relates to chimeric genes and their use in the regulation of biosynthesis and/or production of secondary metabolites in plants and plant-derived cell cultures.
    Type: Application
    Filed: August 21, 2018
    Publication date: March 7, 2019
    Applicants: VIB VZW, Universiteit Gent, Universiteit Leiden
    Inventors: Alain Goossens, Jan Mertens, Alex Van Moerkercke, Jacob Pollier, Johan Memelink
  • Patent number: 9994883
    Abstract: The disclosure relates to a method for enhancing the biosynthesis and/or secretion of sapogenins in the culture medium of plant and microbial cell cultures. Further, the disclosure also relates to the identification of novel genes involved in the biosynthesis of sapogenin intermediates, as well as to novel sapogenin compounds.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: June 12, 2018
    Assignees: VIB VZW, Universiteit Gent
    Inventors: Alain Goossens, Tessa Moses, Jacob Pollier, Lorena Almagro Romero
  • Publication number: 20170159065
    Abstract: This disclosure relates to plants having a decreased expression of the KIX8 and KIX9 genes that result in an increased yield, particularly an increased leaf biomass. The disclosure provides plants and chimeric genes that can be used to decrease the combined KIX8/KIX9 gene expression.
    Type: Application
    Filed: July 8, 2015
    Publication date: June 8, 2017
    Inventors: Dirk Gustaaf Inzé, Alain Goossens, Nathalie Gonzalez, Laurens Pauwels, Alexandra Baekelandt
  • Publication number: 20170009249
    Abstract: This disclosure relates to the field of secondary metabolite production in plants. More specifically, the disclosure relates to chimeric genes and their use in the regulation of biosynthesis and/or production of secondary metabolites in plants and plant-derived cell cultures.
    Type: Application
    Filed: February 18, 2015
    Publication date: January 12, 2017
    Applicants: VIB VZW, UNIVERSITEIT GENT, UNIVERSITEIT LEIDEN
    Inventors: Alain GOOSSENS, Jan MERTENS, Alex van MOERKERCKE, Jacob POLLIER, Johan MEMELINK
  • Publication number: 20150141633
    Abstract: The disclosure relates to a method for enhancing the biosynthesis and/or secretion of sapogenins in the culture medium of plant and microbial cell cultures. Further, the disclosure also relates to the identification of novel genes involved in the biosynthesis of sapogenin intermediates, as well as to novel sapogenin compounds.
    Type: Application
    Filed: May 13, 2013
    Publication date: May 21, 2015
    Inventors: Alain Goossens, Tessa Moses, Jacob Pollier, Lorena Almagro Romero
  • Publication number: 20100170010
    Abstract: The invention relates to the field of secondary metabolite production in plants and plant cell cultures. More specifically, the invention relates to the use of transporters and more particularly ABC-transporters to enhance the production and/or secretion of secondary metabolites in plants and plant cell cultures.
    Type: Application
    Filed: November 24, 2009
    Publication date: July 1, 2010
    Inventors: Alain Goossens, Dirk G Inzé
  • Patent number: 7622634
    Abstract: The invention relates to the field of secondary metabolite production in plants and plant cell cultures. More specifically, the invention relates to the use of transporters and more particularly ABC-transporters to enhance the production and/or secretion of secondary metabolites in plants and plant cell cultures.
    Type: Grant
    Filed: September 18, 2003
    Date of Patent: November 24, 2009
    Assignee: VTT Biotechnology
    Inventors: Alain Goossens, Dirk Gustaaf Inze, Kirsi-Marja Oksman-Caldentey, Into J. Laakso
  • Publication number: 20090165167
    Abstract: The present invention relates to the field of plant secondary metabolites, particularly terpenoid indole alkaloids. More particularly the present invention relates to the production of the anti-cancer metabolites vincristine and vinblastine. The invention provides novel polynucleotide sequences derived from Catharanthus roseus and the use of said polynucleotide sequences to stimulate the production of vinblastine and/or vincristine in plants of Catharanthus roseus and plant cell lines derived thereof. The invention further relates to recombinant plants, plant cells, tissue and organ cultures obtainable by the process of the invention.
    Type: Application
    Filed: September 14, 2006
    Publication date: June 25, 2009
    Inventors: Alain Goossens, Heiko Rischer, Dirk G. Inze, Matej Oresic, Kirsi-Marja Oksman-Caldentey
  • Publication number: 20060041962
    Abstract: The present invention relates to the use of a genome wide expression profiling technology in combination with the detection of the presence of secondary metabolites of interest to isolate genes that can be used to modulate the production of secondary metabolites in organisms and cell lines derived therefrom.
    Type: Application
    Filed: November 16, 2004
    Publication date: February 23, 2006
    Inventors: Dirk Inze, Alain Goossens, Kirsi-Marja Oksman-Caldentey, Suvi Hakkinen, Into Laakso
  • Publication number: 20040064849
    Abstract: The invention relates to the field of secondary metabolite production in plants and plant cell cultures. More specifically, the invention relates to the use of transporters and more particularly ABC-transporters to enhance the production and/or secretion of secondary metabolites in plants and plant cell cultures.
    Type: Application
    Filed: September 18, 2003
    Publication date: April 1, 2004
    Applicant: Vlaams Interuniversitair Instituut Voor Biotechnologie VZW
    Inventors: Alain Goossens, Dirk Gustaaf Inze
  • Publication number: 20030159183
    Abstract: The present invention relates to heterologous gene expression in plants. More specifically, the invention relates to high expression of heterologous proteins in seeds, by incorporating the gene between seed specific sequences. Preferably, the heterologous protein is a single-chain antibody variable fragment (scFv).
    Type: Application
    Filed: December 27, 2002
    Publication date: August 21, 2003
    Inventors: Geert Angenon, Geert De Jaeger, Alain Goossens, Anna Depicker